Internal Medicine, Gastroenterology · Clive, IA
NPI
1972560597
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1378 NW 124th St, Suite 200
Clive, IA, 50325
Phone (515) 288-6097
Groups this clinician bills Medicare through
Medicare paid, 2024
$94K
2,107 services
Medicare patients, 2024
382
Average age 72
Drug cost, 2024
$3.2M
1,554 prescriptions
Company payments, 2025
$2,628
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bernard I Leman was code G0500 (moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito), 214 times for 209 patients. In total Bernard I Leman billed 2,107 services in 37 codes, and Medicare paid $94K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-06.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 214 | 209 | $3.64 | $778 |
| 45385 Colonoscopy - Lesion Removal | Facility | 98 | 94 | $191.03 | $19K |
| 43239 Upper GI Endoscopy | Facility | 75 | 74 | $94.54 | $7,091 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 69 | 69 | $163.74 | $11K |
| 45380 Lower GI Endoscopy - Other | Facility | 64 | 64 | $112.04 | $7,170 |
| 99213 Office E&M - Established | Office | 61 | 54 | $66.30 | $4,044 |
| 99214 Office E&M - Established | Office | 33 | 23 | $79.48 | $2,623 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 26 | 26 | $164.54 | $4,278 |
| 96413 Chemotherapy Administration | Office | 22 | 17 | $91.99 | $2,024 |
| 43450 Digestive/Gastrointestinal | Facility | 21 | 20 | $28.67 | $602 |
By year: 2022 $123K for 4,440 services; 2023 $92K for 2,033 services; 2024 $94K for 2,107 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bernard I Leman prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 189 prescriptions and refills. In total Bernard I Leman wrote 1,554 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 189 | 189 | 187 | $12K |
| Ondansetron Hcl Generic | 139 | 139 | 132 | $118 |
| Pantoprazole Sodium Generic | 116 | 175 | 26 | $1,582 |
| Ondansetron Odt Ondansetron | 95 | 95 | 94 | $107 |
| Stelara Ustekinumab | 73 | 119 | 11 | $2.1M |
| Mesalamine Generic | 69 | 105 | 13 | $22K |
| Balsalazide Disodium Generic | 63 | 125 | 13 | $7,134 |
| Sodium Chloride 0.9 % Sodium Chloride | 51 | 67 | Under 11 | $131 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 47 | 47 | 47 | $771 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 46 | 49 | Under 11 | $2,932 |
| Dicyclomine Hcl Generic | 45 | 61 | Under 11 | $508 |
| Entyvio Vedolizumab | 41 | 56 | Under 11 | $349K |
| Omeprazole Generic | 38 | 109 | 12 | $710 |
| Linzess Linaclotide | 35 | 35 | Under 11 | $19K |
| Sulfasalazine Generic | 34 | 44 | Under 11 | $585 |
Brand drugs: - claims; generic drugs: 1,081 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bernard I Leman $2,628 ($2,628 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $875.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 49 | $875 |
| Phathom Pharmaceuticals, Inc. PHAT | 10 | $354 |
| Lilly USA, LLC LLY | 14 | $312 |
| Janssen Biotech, Inc. JNJ | 8 | $262 |
| Pfizer Inc. PFE | 14 | $161 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 5 | $133 |
| Lumendi LLC | 1 | $92.55 |
| Genzyme Corporation SNY | 4 | $86.79 |
| Gilead Sciences, Inc. GILD | 3 | $71.57 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $62.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.